• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆基质金属蛋白酶和金属蛋白酶组织抑制剂谱可预测电复律后心房颤动的复发。

Plasma profiles of matrix metalloproteinases and tissue inhibitors of the metalloproteinases predict recurrence of atrial fibrillation following cardioversion.

机构信息

Division of Cardiothoracic Surgery, Medical University of South Carolina, 770 MUSC Complex, Suite 326, Charleston, SC 29425, USA.

出版信息

J Cardiovasc Transl Res. 2013 Aug;6(4):528-35. doi: 10.1007/s12265-013-9471-2. Epub 2013 May 31.

DOI:10.1007/s12265-013-9471-2
PMID:23722357
Abstract

Atrial fibrosis is considered to contribute to atrial fibrillation (AF) recurrence following cardioversion. This study tested the hypothesis that circulating levels of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs (TIMPs) can predict AF recurrence postcardioversion. Precardioversion plasma samples (n = 82) were assayed for MMPs (eight types), TIMPs (all four types), N-terminus pro B-type natriuretic peptide, and high-sensitivity C-reactive protein levels. Patients were followed for AF recurrence postcardioversion. Despite 100 % restoration of sinus rhythm, 36 (44 %) reverted to AF within 3 months. Left atrial volume was increased in patients in whom AF recurred. Precardioversion MMP-9 was higher and TIMP-4 lower with AF recurrence. MMP-9, MMP-3, and TIMP-4 independently predicted AF recurrence. In multivariate analysis, combination of MMP-9, MMP-3, and TIMP-4 increased prediction of AF recurrence. Circulating levels of MMPs and TIMPs predict AF recurrence postcardioversion and may be used in a novel biomarker panel to guide AF stratification and therapy.

摘要

心房纤维化被认为是导致电复律后心房颤动(AF)复发的原因。本研究检验了以下假设,即循环中基质金属蛋白酶(MMPs)和基质金属蛋白酶抑制剂(TIMPs)的水平可以预测电复律后的 AF 复发。在电复律前采集血浆样本(n = 82),用于检测 MMP(8 种类型)、TIMP(所有 4 种类型)、N 末端 pro B 型利钠肽和高敏 C 反应蛋白水平。对患者进行电复律后 AF 复发的随访。尽管窦性心律恢复率达到 100%,但仍有 36 例(44%)在 3 个月内复发 AF。AF 复发患者的左心房容积增加。与 AF 复发相关的 MMP-9 在电复律前更高,而 TIMP-4 更低。MMP-9、MMP-3 和 TIMP-4 可独立预测 AF 复发。在多变量分析中,MMP-9、MMP-3 和 TIMP-4 的组合增加了对 AF 复发的预测。循环 MMPs 和 TIMPs 的水平可预测电复律后 AF 的复发,并且可能用于新的生物标志物组合,以指导 AF 的分层和治疗。

相似文献

1
Plasma profiles of matrix metalloproteinases and tissue inhibitors of the metalloproteinases predict recurrence of atrial fibrillation following cardioversion.血浆基质金属蛋白酶和金属蛋白酶组织抑制剂谱可预测电复律后心房颤动的复发。
J Cardiovasc Transl Res. 2013 Aug;6(4):528-35. doi: 10.1007/s12265-013-9471-2. Epub 2013 May 31.
2
Serum amyloid a and C-reactive protein independently predict the recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function.血清淀粉样蛋白 A 和 C 反应蛋白可独立预测左心室功能正常的心房颤动患者电复律后的复发。
Can J Cardiol. 2012 Sep-Oct;28(5):537-41. doi: 10.1016/j.cjca.2012.02.014. Epub 2012 May 1.
3
Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis.血浆基质金属蛋白酶及其组织抑制剂水平与肺结核患者不良治疗结局的相关性。
JAMA Netw Open. 2020 Dec 1;3(12):e2027754. doi: 10.1001/jamanetworkopen.2020.27754.
4
Predictive value of atrial electromechanical delay for atrial fibrillation recurrence.心房电机械延迟对心房颤动复发的预测价值。
Cardiol J. 2013;20(6):639-47. doi: 10.5603/CJ.2013.0164.
5
Association of MMPs and TIMPs With the Occurrence of Atrial Fibrillation: A Systematic Review and Meta-analysis.基质金属蛋白酶及其抑制剂与心房颤动发生的关系:系统评价和荟萃分析。
Can J Cardiol. 2016 Jun;32(6):803-13. doi: 10.1016/j.cjca.2015.08.001. Epub 2015 Aug 12.
6
Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation.二尖瓣疾病和心房颤动患者中的基质金属蛋白酶与心房重构
Cardiovasc Res. 2005 Sep 1;67(4):655-66. doi: 10.1016/j.cardiores.2005.04.016.
7
Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation.心房颤动患者心房和心室心肌中基质金属蛋白酶及金属蛋白酶组织抑制剂的选择性诱导
Am J Cardiol. 2006 Feb 15;97(4):532-7. doi: 10.1016/j.amjcard.2005.08.073. Epub 2006 Jan 4.
8
CHA2DS2-VASc score and blood biomarkers to identify patients with atrial high-rate episodes and paroxysmal atrial fibrillation.CHA2DS2-VASc评分和血液生物标志物用于识别心房高率发作和阵发性心房颤动患者。
Europace. 2017 Apr 1;19(4):544-551. doi: 10.1093/europace/euw101.
9
The predictive value of plasma brain natriuretic peptide for the recurrence of atrial fibrillation six months after external cardioversion.体外心脏复律后六个月血浆脑钠肽对心房颤动复发的预测价值。
Turk Kardiyol Dern Ars. 2008 Oct;36(7):456-60.
10
Effect of sinus rhythm restoration after electrical cardioversion on apelin and brain natriuretic Peptide prohormone levels in patients with persistent atrial fibrillation.电复律后恢复窦性心律对持续性心房颤动患者apelin 和脑钠肽原水平的影响。
Am J Cardiol. 2010 Jan 1;105(1):90-4. doi: 10.1016/j.amjcard.2009.08.656.

引用本文的文献

1
Atrial Cardiomyopathy in Atrial Fibrillation: A Multimodal Diagnostic Framework.心房颤动中的心房心肌病:多模态诊断框架
Diagnostics (Basel). 2025 May 10;15(10):1207. doi: 10.3390/diagnostics15101207.
2
Atrial cardiomyopathy revisited-evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS).心房心肌病再探——概念的演变:欧洲心脏病学会心律协会 (EHRA)、心律学会 (HRS)、亚太心律学会 (APHRS) 和拉丁美洲心律学会 (LAHRS) 的临床共识声明。
Europace. 2024 Aug 30;26(9). doi: 10.1093/europace/euae204.
3

本文引用的文献

1
Role of Left Ventricular Diastolic Dysfunction in Predicting Atrial Fibrillation Recurrence after Successful Electrical Cardioversion.左心室舒张功能障碍在预测电复律成功后房颤复发中的作用
J Atr Fibrillation. 2012 Dec 16;5(4):654. doi: 10.4022/jafib.654. eCollection 2012 Dec.
2
The significance of the left atrial volume index in cardioversion success and its relationship with recurrence in patients with non-valvular atrial fibrillation subjected to electrical cardioversion: a study on diagnostic accuracy.左心房容积指数在非瓣膜性心房颤动患者电复律成功中的意义及其与复发的关系:一项诊断准确性研究
Anadolu Kardiyol Derg. 2013 Feb;13(1):18-25. doi: 10.5152/akd.2013.003. Epub 2012 Oct 12.
3
Left atrial volume index: A predictor of atrial fibrillation recurrence following direct current cardioversion - A systematic review and meta-analysis.
左心房容积指数:直流电复律后房颤复发的预测指标——一项系统评价和荟萃分析
Int J Cardiol Heart Vasc. 2024 Feb 23;51:101364. doi: 10.1016/j.ijcha.2024.101364. eCollection 2024 Apr.
4
Meta-Analysis of Mechano-Sensitive Ion Channels in Human Hearts: Chamber- and Disease-Preferential mRNA Expression.机械敏感离子通道在人心肌中的荟萃分析:房室和疾病偏好性的 mRNA 表达。
Int J Mol Sci. 2023 Jun 30;24(13):10961. doi: 10.3390/ijms241310961.
5
The Role of Major Inflammatory Biomarkers in the Pathogenesis of Atrial Fibrillation.主要炎症生物标志物在心房颤动发病机制中的作用
J Innov Card Rhythm Manag. 2022 Dec 15;13(12):5265-5277. doi: 10.19102/icrm.2022.13125. eCollection 2022 Dec.
6
A potential link between aberrant expression of ECRG4 and atrial fibrillation.ECRG4异常表达与心房颤动之间的潜在联系。
Front Oncol. 2023 Feb 22;13:1031128. doi: 10.3389/fonc.2023.1031128. eCollection 2023.
7
Electrophysiological and Structural Remodeling of the Atria in a Mouse Model of Troponin-I Mutation Linked Hypertrophic Cardiomyopathy: Implications for Atrial Fibrillation.肌钙蛋白 I 突变相关肥厚型心肌病小鼠模型中心房的电生理和结构重构:对心房颤动的影响。
Int J Mol Sci. 2021 Jun 28;22(13):6941. doi: 10.3390/ijms22136941.
8
Racial difference in atrial size and extracellular matrix homeostatic response to hypertension: Is this a potential mechanism of reduced atrial fibrillation in African Americans?心房大小的种族差异以及细胞外基质对高血压的稳态反应:这是非洲裔美国人房颤发生率降低的潜在机制吗?
Heart Rhythm O2. 2021 Jan 12;2(1):37-45. doi: 10.1016/j.hroo.2021.01.001. eCollection 2021 Feb.
9
Recurrent event survival analysis predicts future risk of hospitalization in patients with paroxysmal and persistent atrial fibrillation.复发性事件生存分析预测阵发性和持续性心房颤动患者未来住院风险。
PLoS One. 2019 Jun 7;14(6):e0217983. doi: 10.1371/journal.pone.0217983. eCollection 2019.
10
Relationship between Brain Natriuretic Peptide and Recurrence of Atrial Fibrillation after Successful Electrical Cardioversion: an Updated Meta-Analysis.脑钠肽与电复律成功后房颤复发的关系:一项更新的荟萃分析
Braz J Cardiovasc Surg. 2017 Nov-Dec;32(6):530-535. doi: 10.21470/1678-9741-2017-0008.
The role of fibroblasts in complex fractionated electrograms during persistent/permanent atrial fibrillation: implications for electrogram-based catheter ablation.
成纤维细胞在持续性/永久性心房颤动时复杂碎裂电图中的作用:对基于电图的导管消融的影响。
Circ Res. 2012 Jan 20;110(2):275-84. doi: 10.1161/CIRCRESAHA.111.255026. Epub 2011 Dec 15.
4
Left atrial remodeling and response to valsartan in the prevention of recurrent atrial fibrillation: the GISSI-AF echocardiographic substudy.左心房重构和缬沙坦预防复发性心房颤动的反应:GISSI-AF 超声心动图子研究。
Circ Cardiovasc Imaging. 2011 Nov;4(6):721-8. doi: 10.1161/CIRCIMAGING.111.965954. Epub 2011 Sep 16.
5
The effect of sinus rhythm restoration on high-sensitivity C-reactive protein levels and their association with long-term atrial fibrillation recurrence after electrical cardioversion.窦性心律恢复对高敏C反应蛋白水平的影响及其与电复律后长期房颤复发的关系。
Cardiology. 2011;118(3):168-74. doi: 10.1159/000327998. Epub 2011 Jun 3.
6
Impact of biomarkers of inflammation and extracellular matrix turnover on the outcome of atrial fibrillation ablation: importance of matrix metalloproteinase-2 as a predictor of atrial fibrillation recurrence.炎症和细胞外基质代谢生物标志物对房颤消融结局的影响:基质金属蛋白酶-2作为房颤复发预测因子的重要性。
J Cardiovasc Electrophysiol. 2011 Sep;22(9):987-93. doi: 10.1111/j.1540-8167.2011.02059.x. Epub 2011 Apr 13.
7
Plasma biomarkers that reflect determinants of matrix composition identify the presence of left ventricular hypertrophy and diastolic heart failure.能反映基质组成决定因素的血浆生物标志物可识别左心室肥厚和舒张性心力衰竭的存在。
Circ Heart Fail. 2011 May;4(3):246-56. doi: 10.1161/CIRCHEARTFAILURE.110.958199. Epub 2011 Feb 24.
8
Indexed left atrial volume predicts the recurrence of non-valvular atrial fibrillation after successful cardioversion.左心房容积指数可预测非瓣膜性心房颤动成功复律后的复发情况。
Eur J Echocardiogr. 2011 Mar;12(3):214-21. doi: 10.1093/ejechocard/jeq176. Epub 2010 Dec 11.
9
C-reactive protein, interleukin 6, and N-terminal pro-brain natriuretic peptide following cardioversion of atrial fibrillation: is there a role of biomarkers in arrhythmia recurrence?C 反应蛋白、白细胞介素 6 和氨基末端脑利钠肽前体在心房颤动转复后的变化:生物标志物在心律失常复发中的作用如何?
Angiology. 2011 May;62(4):310-6. doi: 10.1177/0003319710382418. Epub 2010 Sep 11.
10
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).心房颤动管理指南:欧洲心脏病学会(ESC)心房颤动管理特别工作组
Eur Heart J. 2010 Oct;31(19):2369-429. doi: 10.1093/eurheartj/ehq278. Epub 2010 Aug 29.